Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background Poor treatment adherence is common in cystic fibrosis (CF) and may lead to worse health outcomes and greater health-care use. This study evaluated associations of adherence to pulmonary medications, age, health-care use, and cost among patients with CF. Methods Patients with CF aged ≥ 6 years were identified in a national commercial claims database. A 12-month medication possession ratio (MPR) was computed for each pulmonary medication and then averaged for a composite MPR (CMPR) for each patient. The CMPR was categorized as low ( Results Mean CMPR for the sample (N = 3,287) was 48% ± 31%. Age was inversely related to CMPR. In the concurrent year, more CF-related hospitalizations were observed among patients with low (event rate ratio [ERR], 1.35; 95% CI, 1.15-1.57) and moderate (ERR, 1.25; 95% CI, 1.05-1.48) vs high adherence; similar associations were observed for all-cause hospitalizations and CF-related and all-cause acute care use (hospitalizations + ED) in the concurrent and subsequent year. Rates of CF-related and all-cause outpatient visits did not differ by adherence. Low and moderate adherence predicted higher concurrent health-care costs by $14,211 ($5,557-$24,371) and $8,493 (-$1,691 to $19,709), respectively, compared with high adherence. Conclusions Worse adherence to pulmonary medications was associated with higher acute health-care use in a national, privately insured cohort of patients with CF. Addressing adherence may reduce avoidable health-care…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low adherence to all treatments is associated with an increased number of pulmonary exacerbations requiring intravenous (IV) antibiotics (Eakin 2011) and hospitalisations, which incur higher healthcare costs (Quittner 2014).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Quittner 2014
Citations
Cites
Physician Communication and Patient Adherence to Treatment: A Meta-Analysis
Haskard Zolnierek, K. B., & DiMatteo, M. R. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819a5acc · Cited by 2,489
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
Elkins, M. R., Robinson, M., Rose, B. R., Harbour, C., Moriarty, C. P., Marks, G. B., Belousova, E. G., Xuan, W., & Bye, P. T. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043900 · Cited by 862
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Mueller, G., Hadjiliadis, D., Hoag, J. B., Lubsch, L., Hazle, L., Sabadosa, K., Marshall, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1160oe · Cited by 615
Kahana, S., Drotar, D., & Frazier, T. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm128 · Cited by 334
How patient cost-sharing trends affect adherence and outcomes: a literature review.
Eaddy, M. T., Cook, C. L., O'Day, K., Burch, S. P., & Cantrell, C. R. (2012) · Europe PMC (PubMed Central) · Cited by 329
Barriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
Modi, A. C., & Quittner, A. L. (2006) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj096 · Cited by 301
Self-citationA multi-method assessment of treatment adherence for children with cystic fibrosis
Modi, A. C., Lim, C. S., Yu, N., Geller, D., Wagner, M. H., & Quittner, A. L. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.03.002 · Cited by 265
Self-citation
Research works printed but not linked: 2
- Pressler, 2011, Aztreonam for inhalation solution, an aerosolized antibiotic for the treatment of pseudomonal airway infection in patients with cystic fibrosis, US Res Dis, 7, 107
- Quinn, 2004, Measuring, predicting and improving adherence to inhalation in patients with CF: a randomised controlled study of motivational interviewing [abstract], Pediatr Pulmonol, 38, 360
Cited by
Items 201–251 of 251
Barriers to Treatment Adherence in Adolescents with Cystic Fibrosis: A Mixed-Methods Analysis
McLean, K. A. (2015) · Cited by 1
The Effect of Long Term Use of Inhaled N-Acetylcysteine on Cystic Fibrosis Lung Disease
Demirel, N. (2020) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
(2020) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-020-0790-z · Cited by 2
Knudsen, K. B., Pressler, T., Mortensen, L. H., Jarden, M., Skov, M., Quittner, A. L., Katzenstein, T. L., & Boisen, K. A. (2016) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(16)30088-1
Self-citationLifestyle treatments in cystic fibrosis: The NHS should pay
Ketchell, R. I. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.06.006
Mann, N., Murray, S., Hoo, Z. H., Curley, R., & Wildman, M. J. (2018) · F1000Research · doi:10.12688/f1000research.13298.2
Adults With Cystic Fibrosis: Self-Management And Health Outcomes
Lambie, A. R. (2018) · ISU Red - Research and eData (Illinois State University) · doi:10.30707/etd2018.lambie.a
Saliba, D. (2019) · TSpace (University of Toronto) · Cited by 1
Garcia, B. A., Mattson, J., & Flume, P. A. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_11
Banks, J. T., Rosenfeld, M., Mancl, L., & Donald, L. (2020) · International Journal of Paediatric Dentistry · doi:10.1111/ipd.12724
The role of beliefs in predicting adherence to nebulised therapy in adolescents with cystic fibrosis
Stirzaker, B. M. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Yigitbas, B., Satıcı, C., & Niksarlıoğlu, E. Y. Ö. (2020) · Eurasian Journal of Pulmonology · doi:10.4103/ejop.ejop_71_20
Păduraru, A. E., Azoicăi, D., & Soponaru, C. (2020) · The Medical-Surgical Journal
Patient expectations and regulatory needs in the risk-based drug development of cystic fibrosis
Pallagi, E., & Csóka, I. (2021) · Acta Pharmaceutica Hungarica · doi:10.33892/aph.2021.91.3-10
“Co-morbidities and their therapy [7] are also an addition-”
BackgroundMonteiro, K. S., Santino, T. A., Pakhale, S. S., Balfour, L., & de Mendonça, K. M. P. P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259232 · Cited by 1
“Current studies have highlighted the importance of knowledge about the disease to increase treatment adherence [11–13, 43], and thereby reduce the number of hospitalizations and increase the life expectancy of people with CF [3, 8, 9, 44].”
BackgroundArden, M. A., Hutchings, M., Whelan, P., Drabble, S. J., Beever, D., Bradley, J. M., Hind, D., Ainsworth, J. D., Maguire, C., Cantrill, H., et al. (2020) · doi:10.31234/osf.io/gbcpk
Mês Nacional de Conscientização da Fibrose Cística no Brasil
. (2019) · Visão Acadêmica · doi:10.5380/acd.v20i3.1.69506
Martin, C., Chelabi, S., & Burgel, P. (2015) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(15)30073-2
Sayer, K., Church, D., Grady, A., & Thomas, A. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/qopl9891
Lewis, M. A., & Twose, P. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/blrh7152
Shepherd, E., Douglas, H., & Osman, L. (2022) · Journal of the Association of Chartered Physiotherapists in Respiratory Care · doi:10.56792/vwji7953
Mittaine, M., Roditis, L., & Dupuis, M. (2023) · médecine/sciences · doi:10.1051/medsci/2022200 · Cited by 1
Eaton, C. K., McWilliams, E., Yablon, D., Kesim, I., Ge, R., MIRUS, K. A., Sconiers, T., Donkoh, A., Lawrence, M., George, C., et al. (2023) · doi:10.2196/preprints.49024
Self-citationFranco, R., Elbert, A., & Wu, R. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01370-x
Despotes, K., Ceppe, A., Donaldson, S. H., & Goralski, J. L. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01508-4
Herrmann, D., Lee, C., & Vasquez, E. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01369-3
587 Transitions-of-care outcomes in the postmodulator era
McIntyre, S., & Tolle, J. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01509-6
Button, B., Wagner, M., Plešková, J., & Talbot, A. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01371-1
588 Data quality audit of the Australian Cystic Fibrosis Data Registry: a pilot study
Ruseckaite, R., Caruso, M., & Ahern, S. (2023) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(23)01510-2
Complexidade da farmacoterapia em pacientes pediátricos com fibrose cística
Leyraud, S. Z., & de Matos, D. N. (2023) · doi:10.58203/licuri.21269
Evaluation of Cystic Fibrosis Medication Adherence and Barriers in 2020 and 2022Preprint
Belmonte, L., Fleischman, M. E., Hinz, R., & Wendland, E. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4627103
Additional file 2 of Prognosis and treatment of 46 Chinese pediatric cystic fibrosis patients
Chen, Q., Shen, Y., Xu, H., Tang, X., Yang, H., & Zhao, S. (2021) · Figshare · doi:10.6084/m9.figshare.15063301
Process and validity of linking cystic fibrosis patient registry with national Medicaid databases
Esther, C. R., Rua, M., Chen, H., Cromwell, E. A., & Setoguchi, S. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.10.012
Duncan, C. L., Muther, E., Lindwall, J. J., Durkin, K., Ruvalcaba, E., Williamson, E., Ahrabi-Nejad, C. N., Bord, E., Green, A., Harrison, M., et al. (2025) · Journal of Participatory Medicine · doi:10.2196/49941 · Cited by 1
“It is not surprising, then, that adherence to prescribed treatment regimens is a common problem in CF, with adherence rates to all CF treatments ranging from 35% to 75%, while CF medication-specific adherence spans 31% to 79% [11-13].”
Panahishokouh, M., Kasaeian, A., Jafarrangraz, S. S., & Amini, S. (2025) · Journal of Reports in Pharmaceutical Sciences · doi:10.5812/jrps-157150
Eid, E., Payet, C., Fernandez, V., Belhassen, M., Bessou, A., Durieu, I., Reynaud, Q., & Viprey, M. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2026.108857 · Cited by 1
Holmes, M., Palladino, M., Ho, H. Y., Malajczuk, C. J., Karpievitch, Y. V., Yeoh, D. K., Edmiston, P., & Schultz, A. (2025) · Pediatric Pulmonology · doi:10.1002/ppul.71379
“In general, non ‐ adherence to medical therapy in CF is associated with increased incidence of hospital admissions for pulmonary exacerbations and declining lung function [19], along with current and prospective health care presentations and their economic consequences [20].”
Reda, H., Ahmed, S., Sturza, J. S., & Nasr, S. Z. (2025) · JPGN Reports · doi:10.1002/jpr3.70124
Richards, B., Osborne, S. R., & Simons, M. (2022) · Figshare · doi:10.6084/m9.figshare.19068792
Additional file 1 of Prognosis and treatment of 46 Chinese pediatric cystic fibrosis patients
Chen, Q., Shen, Y., Xu, H., Tang, X., Yang, H., & Zhao, S. (2021) · Figshare · doi:10.6084/m9.figshare.15063295
Richards, B., Osborne, S. R., & Simons, M. (2022) · Figshare · doi:10.6084/m9.figshare.19068801
Richards, B., Osborne, S. R., & Simons, M. (2022) · Figshare · doi:10.6084/m9.figshare.19068798
Richards, B., Osborne, S. R., & Simons, M. (2022) · Figshare · doi:10.6084/m9.figshare.19068804
Arden, M. A., Hutchings, M., Whelan, P., Drabble, S. J., Beever, D., Bradley, J. M., Hind, D., Ainsworth, J. D., Maguire, C., Cantrill, H., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13515664
Friedman, D., Quittner, A. L., Bruce, A. S., Smith, B. A., He, J., Chaudhary, N., Boutwell, A., Wei, R., Mullen, T. M. D., Roach, C. M., et al. (2026) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsag006
Self-citationSaag, J. L., Bergeron, J., Bailey, J., Monroe, K., Hathorne, H. Y., Solomon, G. M., Lowman, J. D., Bhatt, S. P., Garcia, B., & Krick, S. (2026) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk11020136
“However, due to the time commitment for the many medical treatments that pwCF already have, adherence to exercise and even their regular treatments has been problematic in the past and are not well studied [6,7].”
Terlizzi, V., Graziano, S., Presti, S., Malanima, M. A., Fevola, C., Castaldo, A., Teodori, C., Bresci, S., Avarello, A., Quittner, A. L., et al. (2026) · Pulmonology · doi:10.1016/s1569-1993(26)01230-0
Self-citationLorenz, M., Pavlova, M., Erler, K., Nader, A., & Moeser, A. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1888421
“…particularly relevant for adolescents and young adults, a developmental period associated with shifting responsibility for self-management, changing routines, and increased vulnerability to competing social and educational demands — factors that can destabilize adherence patterns over time (3, 5).”
InfluentialAssessment of pMDI inhaler technique in children and adolescents with cystic fibrosis
Bastos, A. M. C., Pone, M. V. D. S., Costa, P. F. B. M., Varela, M. C., & Gomes, S. C. D. S. (2026) · Jornal de Pediatria · doi:10.1016/j.jped.2026.101624
“Adherence to inhaled therapies — already recognized as lower than that observed with other routes of administration [7,9] — is associated with longer hospitalizations, frequent pulmonary exacerbations, and decline in lung function [8,10].”
de Oliveira, M. S., Martins, C. H., de Moura, D. C., Leite, L. R., & Aquino, E. D. S. (2026) · Brazilian Journal of Respiratory Cardiovascular and Critical Care Physiotherapy · doi:10.47066/2966-4837.e00262025pt
de Oliveira, M. S., Martins, C. H., de Moura, D. C., Leite, L. R., & Aquino, E. D. S. (2026) · Brazilian Journal of Respiratory Cardiovascular and Critical Care Physiotherapy · doi:10.47066/2966-4837.e00262025en
“A previous study showed that low adherence is associated with increased healthcare costs due to a higher frequency of pulmonary exacerbations 18 .”
Metadata
- Authors
- Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A.
- Affiliations
- University of Miami (US)
- Novartis (United States) (US)
- Analysis Group (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Quittner, Alexandra L.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 146
- Issue
- 1
- Pages
- 142-151
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2070450626
- Cited by
- 250
- References
- 28
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 11 · 2023: 24 · 2022: 28 · 2021: 20 · 2020: 29 · 2019: 23 · 2018: 20 · 2017: 28 · 2016: 15 · 2015: 22 · 2014: 6
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- cystic fibrosis, medication adherence, medication possession ratio, health care utilization, hospitalization, health care costs, outpatient visits, emergency department visits, age, privately insured patients
- MeSH terms
- Adolescent, Adult, Child, Cystic Fibrosis, Delivery of Health Care, Female, Follow-Up Studies, Humans, Immunosuppressive Agents, Male, Patient Compliance, Retrospective Studies, Health Care Costs, Disease Management, Medication Adherence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.